Second-generation sirolimus-eluting absorbable metal scaffold demonstrates favorable outcomes in de novo coronary artery lesions, as reported by the BIOSOLVE-II trial.
The American College of Cardiology and the American Heart Association cholesterol management guidelines have broadened patient eligibility for statin therapy.
Despite a decline in tobacco use, healthcare costs for PAD-related hospitalizations have increased.
Risk scores from the Multi-Ethnic Study of Atherosclerosis (MESA) study, which combine traditional risk factors with coronary artery calcium (CAC) measurements, increase accuracy of CVD risk prediction.
Replacing saturated fats and sugary carbohydrates with unsaturated fats reduces the risk of coronary heart disease.
Ten new genes have been found to be associated with coronary artery disease susceptibility.
Fractional flow reserve technology combined with computed tomographic angiography (FFRCT) offers a reliable, non-invasive source of blood flow measurements.
Mortality lower among those who underwent rehabilitation after hospitalization for coronary heart disease.
Dyslipidemia guidelines, and how to incorporate them into clinical practice, were addressed at the American Association of Diabetes Education meeting.
Familial factors may indicate an increased risk of hypertension for pregnant women.
